Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
4.08 USD | -0.49% | -1.91% | +147.59% |
05-07 | HC Wainwright Adjusts Price Target on ADC Therapeutics to $8 From $9, Maintains Buy Rating | MT |
05-06 | Rate Cut Hopes Lift Exchange-Traded Funds, Equity Futures Pre-Bell Monday | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+147.59% | 395M | |
+9.73% | 115B | |
+12.14% | 106B | |
-2.59% | 21.96B | |
-12.42% | 21.87B | |
-5.29% | 19.21B | |
-3.53% | 18.08B | |
-38.57% | 17.71B | |
+6.99% | 14.32B | |
+35.82% | 12.42B |
- Stock Market
- Equities
- ADCT Stock
- News ADC Therapeutics SA
- ADC Therapeutics Shares Rise After Completion of Dose Escalation Part of Phase 1b Lymphoma Trial